
Novonesis Investor Relations Material
Latest events

Q1 2025
Novonesis
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Novonesis
Access all reports
Novonesis develops, produces and sells industrial enzymes, microorganisms and probiotics. The products convert raw materials into food, beverages and biofuels; they also improve the production of crops and plant products, as well as animal feed. Manufacturing microorganisms, enzymes and probiotics for the industrial, biotech and food markets, Novonesis creates innovative solutions that improve their customers' fermentation processes. Their development centres in Europe, USA and Asia help the company to develop consistent and cost-efficient solutions for their partners worldwide.
Key slides for Novonesis


M&A Announcement
Novonesis


Q1 2025
Novonesis
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
NSIS
Country
🇩🇰 Denmark